S.C.R. No. 33 Summary

• Calls on Congress to seek withdrawal of the U.S. Preventive Services Task Force (USPSTF) October 2011 recommendation against prostate-specific antigen (PSA)-based screening for prostate cancer in men of all age groups.

• Notes that prostate cancer is the most commonly diagnosed nonskin cancer in men, the second leading cause of cancer-related deaths in men, with an estimated 241,740 new diagnoses and 28,170 deaths nationally in 2012, and approximately 7,961 new diagnoses and 1,232 deaths annually in Ohio.

• Argues that the USPSTF recommendation is problematic because it lacks participation from urologists or oncologists and disregards the fact that African-American men have substantially higher prostate cancer incidence and mortality rates than Caucasian men.

• Cites the Goteborg Randomized Population-based Prostate Cancer Screening Trial, which found a 44 percent reduction in prostate cancer deaths over 14 years with screening compared to unscreened men.

• Directs the Senate Clerk to transmit copies of the resolution to each member of Ohio's Congressional delegation.